August 10, 2014 at 09:00
Dubois et al, ASHLB 2014
Related entries:
- 09/14/2014 - Dubois et al, SOHO 2014
- 08/10/2014 - Dubois et al, ASHLB 2014
- 02/05/2015 - Dubois et al, Oncotarget 2015
Poster
First ASH Meeting on Lymphoma Biology (Colorado Springs, Colorado, USA)
EZH2-Activating Mutations in DLBCL Are Easily Predictable by Routine Immunohistochemistry Analysis: a Tool to More Efficiently Define EZH2 Inhibitor-Sensitive Patients ?
Dubois S, Mareschal S, Cornic M, Picquenot JM, Bohers E, Alcantara M, Maingonnat C, Bertrand P, Ruminy P, Bastard C, Tilly H, Jardin F
First ASH Meeting on Lymphoma Biology (Colorado Springs, Colorado, USA)
EZH2-Activating Mutations in DLBCL Are Easily Predictable by Routine Immunohistochemistry Analysis: a Tool to More Efficiently Define EZH2 Inhibitor-Sensitive Patients ?
Dubois S, Mareschal S, Cornic M, Picquenot JM, Bohers E, Alcantara M, Maingonnat C, Bertrand P, Ruminy P, Bastard C, Tilly H, Jardin F